Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Nontuberculous Mycobacteria in Portugal: Trends from the last decade
A. Santos; S. Carneiro; A. Silva; J.P. Gomes; R. Macedo;
Pulmonol. 2024;30:337-43
Improving non-small-cell lung cancer survival through molecular characterization: Perspective of a multidisciplinary expert panel
M.G.O. Fernandes; A.S. Vilariça; B. Fernandes; C. Camacho; C. Saraiva; F. Estevinho; H. Novais e Bastos; J.M. Lopes; P. Fidalgo; P. Garrido; S. Alves; S. Silva; T. Sequeira; F. Barata;
Pulmonol. 2024;30:4-7
Impact of systemic inflammatory markers in patients with ALK-positive non-small cell lung cancer treated with crizotinib
O.F. Olmez; A. Bilici; P. Gursoy; E. Cubukcu; A. Sakin; T. Korkmaz; I. Cil; B. Cakar; S. Menekse; T. Demir; O. Acikgoz; J. Hamdard;
Pulmonol. 2023;29:478-85